Suppression of myocardial glucose metabolism in FDG PET/CT: impact of dose variation in heparin bolus pre-administration

被引：0
|
作者：
A. M. Scholtens
A. M. van den Berk
N. L. van der Sluis
J. P. Esser
G. K. Lammers
J. M. H. de Klerk
M. G. E. H. Lam
H. J. Verberne
机构：
[1] Meander Medical Center,Department of Nuclear Medicine
[2] University Medical Center Utrecht,Department of Radiology and Nuclear Medicine
[3] Academic Medical Center,Department of Radiology and Nuclear Medicine
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2020年 / 47卷
关键词：
FDG PET/CT; Cardiac glucose metabolism; Low carbohydrate diet; Heparin; Infection; Inflammation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2698 / 2702
页数：4
相关论文
共 16 条
  • [1] Suppression of myocardial glucose metabolism in FDG PET/CT: impact of dose variation in heparin bolus pre-administration
    Scholtens, A. M.
    van den Berk, A. M.
    van der Sluis, N. L.
    Esser, J. P.
    Lammers, G. K.
    de Klerk, J. M. H.
    Lam, M. G. E. H.
    Verberne, H. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (11) : 2698 - 2702
  • [2] Does Additional Low Dose Heparin Pre-administration Improve Cardiac Glucose Metabolism Suppression in FDG PET/CT?
    van der Zee, N. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S846 - S846
  • [3] Use of unfractionated heparin for the suppression of myocardial glucose metabolism in 18F-FDG PET/CT studies
    Suarez Fernandez, J. P.
    Gonzalez Garcia, F. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2021, 40 (01): : 67 - 68
  • [4] Heparin does not improve myocardial glucose metabolism suppression in [18 F]FDG PET/CT in patients with low β-hydroxybutyrate level
    Hartikainen, Suvi
    Vepsalainen, Ville
    Laitinen, Tiina
    Hedman, Marja
    Laitinen, Tomi
    Tompuri, Tuomo
    EJNMMI RESEARCH, 2024, 14 (01):
  • [5] FDG PET/CT in Assessing the Association Between Myocardial Glucose Metabolism and Blood Pressure
    Rojulpote, Chaitanya
    Seraj, Siavash Mehdizadeh
    Zadeh, Mahdi Zirakchian
    Yadav, Divya
    Al-Zaghal, Abdullah
    Werner, Thomas
    Gerke, Oke
    Hoilund-Carlsen, Poul Flemming
    Alavi, Abass
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [6] The prognostic value of myocardial glucose metabolism using dynamic FDG PET/CT in patients with ischemic cardiomyopathy
    Ko, Kuan-Yin
    Wu, Yen-Wen
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [7] Point-of-care β-hydroxybutyrate measurement predicts adequate glucose metabolism suppression in cardiac FDG-PET/CT
    Hartikainen, Suvi
    Tompuri, Tuomo
    Laitinen, Tiina
    Laitinen, Tomi
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2024, 44 (05) : 349 - 358
  • [8] Impact of Plasma Glucose Level at the Time of Fluorodeoxyglucose Administration on the Accuracy of FDG-PET/CT in the Diagnosis of Pancreatic Lesions
    Jahromi, Alireza Hamidian
    Fallahzadeh, Mohammad Kazem
    Takalkar, Amol
    Sheng, Jean
    Zibari, Gazi
    Amiri, Hosein Shokouh
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2014, 12 (04)
  • [9] Additional Heparin Preadministration Improves Cardiac Glucose Metabolism Suppression over Low-Carbohydrate Diet Alone in 18F-FDG PET Imaging
    Scholtens, Asbjorn M.
    Verberne, Hein J.
    Budde, Ricardo P. J.
    Lam, Marnix G. E. H.
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (04) : 568 - 573
  • [10] The performance of nicotinic acid in shifting myocardial metabolism to glucose in 18F-labeled 2-deoxyglucose (FDG) PET-CT myocardial viability assessment
    Nordin, A.
    Saad, F. Ahmad
    Aziz, A. Abdul
    Azman, A.
    Azliza, W.
    Ahmad, W. Wan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S427 - S427
12